(1) Glenner, G. G.; Wong, C. W. Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 1984, 120, 885 – 890.
(2) Masters, C. L.; Simms, G.; Weinman, N. A.; Multhaup, G.; McDonald, B. L.; Beyreuther, K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 1985, 82, 4245–4249.
(3) Salvadores, N.; Shahnawaz, M.; Scarpini, E.; Tagliavini, F.; Soto, C. Detection of misfolded Aβ oligomers for sensitive biochemical diagnosis of Alzheimer’s disease. Cell Rep. 2014, 7, 261 – 268.
(4) Vassar, R.; Bennett, B. D.; Babu-Khan, S.; Kahn, S.; Mendiaz, E. A.; Denis, P.; Teplow, D. B.; Ross, S.; Amarante, P.; Loeloff, R. et al. β-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999, 286, 735–741.
(5) Bernstein, S. L.; Dupuis, N. F.; Lazo, N. D.; Wyttenbach, T.; Condron, M. M.; Bitan, G.; Teplow, D. B.; Shea, J. E.; Ruotolo, B. T.; Robinson, C. V. et al. Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer’s disease. Nat. Chem. 2009, 1, 326–331.
(6) Economou, N. J.; Giammona, M. J.; Do, T. D.; Zheng, X.; Teplow, D. B.; Buratto, S. K.; Bowers, M. T. Amyloid β-protein assembly and Alzheimer’s disease: dodecamers of Aβ42, but not of Aβ40, seed fibril formation. J. Am. Chem. Soc. 2016, 138, 1772– 1775.
(7) Stroud, J. C.; Liu, C.; Teng, P. K.; Eisenberg, D. Toxic fibrillar oligomers of amyloid-β have cross-β structure. Proc. Natl. Acad. Sci. USA 2012, 109, 7717–7722.
(8) Shea, D.; Hsu, C.-C.; Bi, T. M.; Paranjapye, N.; Childers, M. C.; Cochran, J.; Tomberlin, C. P.; Wang, L.; Paris, D.; Zonderman, J. et al. α-sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 2019, 116, 8895–8900.
(9) Lührs, T.; Ritter, C.; Adrian, M.; Riek-Loher, D.; Bohrmann, B.; Döbeli, H.; Schubert, D.; Riek, R. 3D structure of Alzheimer’s amyloid-β1−42 fibrils. Proc. Natl. Acad. Sci. USA 2005, 102, 17342–17347.
(10) Lee, J.; Culyba, E. K.; Powers, E. T.; Kelly, J. W. Amyloid-β forms fibrils by nucleated conformational conversion of oligomers. Nat. Chem. Biol. 2011, 7, 602–609.
(11) Hardy, J.; Higgins, G. Alzheimer’s disease: the amyloid cascade hypothesis. Science 1992, 256, 184–185.
(12) Lorenzo, A.; Yankner, B. A. Amyloid fibril toxicity in Alzheimer’s disease and diabetes. Ann. NY Acad. Sci. 1996, 777, 89–95.
(13) Balducci, C.; Beeg, M.; Stravalaci, M.; Bastone, A.; Sclip, A.; Biasini, E.; Tapella, L.; Colombo, L.; Manzoni, C.; Borsello, T. et al. Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. USA 2010, 107, 2295–2300.
(14) He, Y.; Zheng, M.-M.; Ma, Y.; Han, X.-J.; Ma, X.-Q.; Qu, C.-Q.; Du, Y.-F. Soluble oligomers and fibrillar species of amyloid β-peptide differentially affect cognitive functions and hippocampal inflammatory response. Biochem. Biophys. Res. Commun. 2012, 429, 125 – 130.
(15) Kato, M.; Kinoshita, H.; Enokita, M.; Hori, Y.; Hashimoto, T.; Iwatsubo, T.; Toyo’oka, T. Analytical method for β-amyloid fibrils using CE-laser induced fluorescence and its application to screening for inhibitors of β-amyloid protein aggregation. Anal. Chem. 2007, 79, 4887–4891.
(16) Morris, A. M.; Watzky, M. A.; Finke, R. G. Protein aggregation kinetics, mechanism, and curve-fitting: A review of the literature. Biochim. Biophys. Acta (BBA) - Proteins and Proteomics 2009, 1794, 375 – 397.
(17) Banerjee, S.; Hashemi, M.; Lv, Z.; Maity, S.; Rochet, J. C.; Lyubchenko, Y. L. A novel pathway for amyloids self-assembly in aggregates at nanomolar concentration mediated by the interaction with surfaces. Sci. Rep. 2017, 7, 1–11.
(18) Biancalana, M.; Koide, S. Molecular mechanism of thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta (BBA) - Proteins and Proteomics 2010, 1804, 1405 – 1412.
(19) Woody, R. W. Circular dichroism. Methods in Enzymol. 1995, 246, 34 – 71.
(20) Ogi, H.; Fukushima, M.; Hamada, H.; Noi, K.; Hirao, M.; Yagi, H.; Goto, Y. Ultrafast propagation of β-amyloid fibrils in oligomeric cloud. Sci. Rep. 2015, 4, 6960.
(21) Ogi, H.; Fukushima, M.; Uesugi, K.; Yagi, H.; Goto, Y.; Hirao, M. Acceleration of deposition of Aβ1−40 peptide on ultrasonically formed Aβ1−40 nucleus studied by wireless quartz-crystal-microbalance biosensor. Biosens. Bioelectron. 2013, 40, 200 – 205.
(22) Barnes, C. A.; Robertson, A. J.; Louis, J. M.; Anfinrud, P.; Bax, A. Observation of β-amyloid peptide oligomerization by pressure-jump NMR spectroscopy. J. Am. Chem. Soc. 2019, 141, 13762–13766.
(23) Kotler, S. A.; Brender, J. R.; Vivekanandan, S.; Suzuki, Y.; Yamamoto, K.; Monette, M.; Krishnamoorthy, J.; Walsh, P.; Cauble, M.; Holl, M. M. et al. High-resolution NMR characterization of low abundance oligomers of amyloid-β without purification. Sci. Rep. 2015, 5, 1–12.
(24) Watanabe-Nakayama, T.; Ono, K.; Itami, M.; Takahashi, R.; Teplow, D. B.; Yamada, M. High-speed atomic force microscopy reveals structural dynamics of amyloid β1−42 aggregates. Proc. Natl. Acad. Sci. USA 2016, 113, 5835–5840.
(25) Lane, R. E.; Korbie, D.; Anderson, W.; Vaidyanathan, R.; Trau, M. Analysis of exosome purification methods using a model liposome system and tunable-resistive pulse sensing. Sci. Rep. 2015, 5 .
(26) Laganowsky, A.; Liu, C.; Sawaya, M. R.; Whitelegge, J. P.; Park, J.; Zhao, M.; Pensalfini, A.; Soriaga, A. B.; Landau, M.; Teng, P. K. et al. Atomic view of a toxic amyloid small oligomer. Science 2012, 335, 1228–1231.
(27) De Jonge, N.; Ross, F. M. Electron microscopy of specimens in liquid. Nat. Nanotech. 2011, 6, 695–704.
(28) Le Ferrand, H.; Duchamp, M.; Gabryelczyk, B.; Cai, H.; Miserez, A. Time-resolved observations of liquid-iquid phase separation at the nanoscale using in situ liquid transmission electron microscopy. J. Am. Chem. Soc. 2019, 141, 7202–7210.
(29) Yamazaki, T.; Kimura, Y.; Vekilov, P. G.; Furukawa, E.; Shirai, M.; Matsumoto, H.; Van Driessche, A. E. S.; Tsukamoto, K. Two types of amorphous protein particles facilitate crystal nucleation. Proc. Natl. Acad. Sci. USA 2017, 114, 2154–2159.
(30) Bahri, M.; Dembélé, K.; Sassoye, C.; Debecker, D. P.; Moldovan, S.; Gay, A. S.; Hirlimann, C.; Sanchez, C.; Ersen, O. In situ insight into the unconventional ruthenium catalyzed growth of carbon nanostructures. Nanoscale 2018, 10, 14957–14965.
(31) D’Amico, M.; Di Carlo, M. G.; Groenning, M.; Militello, V.; Vetri, V.; Leone, M. Thioflavin T promotes Aβ1−40 amyloid fibrils formation. J. Phys. Chem. Lett. 2012, 3, 1596–1601.
(32) Kumar, H.; Singh, J.; Kumari, P.; Udgaonkar, J. B. Modulation of the extent of structural heterogeneity in α-synuclein fibrils by the small molecule thioflavin T. J. Biol. Chem. 2017, 292, 16891–16903.
(33) Holtz, M. E.; Yu, Y.; Gao, J.; Abruña, H. D.; Muller, D. A. In situ electron energy-loss spectroscopy in liquids. Microsc. Microanal. 2013, 19, 1027–1035.
(34) Alberti, S.; Gladfelter, A.; Mittag, T. Considerations and challenges in studying liquidliquid phase separation and biomolecular condensates. Cell 2019, 176, 419 – 434.
(35) Lesné, S.; Ming, T. K.; Kotilinek, L.; Kayed, R.; Glabe, C. G.; Yang, A.; Gallagher, M.; Ashe, K. H. A specific amyloid-β protein assembly in the brain impairs memory. Nature 2006, 440, 352–357.
(36) Cheng, I. H.; Scearce-Levie, K.; Legleiter, J.; Palop, J. J.; Gerstein, H.; Bien-Ly, N.; Puoliväli, J.; Lesné, S.; Ashe, K. H.; Muchowski, P. J. et al. Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J. Biol. Chem. 2007, 282, 23818–23828.
(37) Eisenberg, D.; Jucker, M. The amyloid state of proteins in human diseases. Cell 2012, 148, 1188 – 1203.
(38) Catti, M.; Ferraris, G.; Franchini-Angela, M. The crystal structure of Na2HPO42H2O. Competition between coordination and hydrogen bonds. Acta Crystallogr. B Struct. Cryst. Cryst. Chem. 1977, 33, 3449–3452.
(39) Baur, W. H.; Khan, A. A. On the crystal chemistry of salt hydrates. VI. The crystal structures of disodium hydrogen orthoarsenate heptahydrate and of disodium hydrogen orthophosphate heptahydrate. Acta Crystallogr. B Struct. Cryst. Cryst. Chem. 1970, 26, 1584–1596.
(40) Foley, J.; Hill, S. E.; Miti, T.; Mulaj, M.; Ciesla, M.; Robeel, R.; Persichilli, C.; Raynes, R.; Westerheide, S.; Muschol, M. Structural fingerprints and their evolution during oligomeric vs. oligomer-free amyloid fibril growth. J. Chem. Phys. 2013, 139, 121901.
(41) Miti, T.; Mulaj, M.; Schmit, J. D.; Muschol, M. Stable, metastable, and kinetically trapped amyloid aggregate phases. Biomacromol. 2015, 16, 326–335.
(42) Hasecke, F.; Miti, T.; Perez, C.; Barton, J.; Schölzel, D.; Gremer, L.; Grüning, C. S. R.; Matthews, G.; Meisl, G.; Knowles, T. P. J. et al. Origin of metastable oligomers and their effects on amyloid fibril self-assembly. Chem. Sci. 2018, 9, 5937–5948.
(43) Perez, C.; Miti, T.; Hasecke, F.; Meisl, G.; Hoyer, W.; Muschol, M.; Ullah, G. Mechanism of fibril and soluble oligomer formation in amyloid beta and hen egg white lysozyme proteins. J. Phys. Chem. B 2019, 123, 5678–5689.
(44) Chakraborty, S.; Das, P. Emergence of alternative structures in amyloid beta1−42 monomeric landscape by N-terminal hexapeptide amyloid inhibitors. Sci. Rep. 2017, 7, 1–12.
(45) Zhao, J.; Nussinov, R.; Ma, B. Mechanisms of recognition of amyloid-β (Aβ) monomer, oligomer, and fibril by homologous antibodies. J. Biol. Chem. 2017, 292, 18325–18343.
(46) Zhou, X.; Xu, J. Free cholesterol induces higher β-sheet content in Aβ oligomers by aromatic interaction with Phe19. PLOS ONE 2012, 7, 1–8.
(47) Zhang, Y.; Hashemi, M.; Lv, Z.; Williams, B.; Popov, K. I.; Dokholyan, N. V.; Lyubchenko, Y. L. High-speed atomic force microscopy reveals structural dynamics of α-synuclein monomers and dimers. J. Chem. Phys. 2018, 148, 123322.
(48) Hill, S. E.; Miti, T.; Richmond, T.; Muschol, M. Spatial extent of charge repulsion regulates assembly pathways for lysozyme amyloid fibrils. PLOS ONE 2011, 6, 1–12.
(49) Mullin, J. W. Crystallization, Third Edition. Chemie Ingenieur Technik 1998, 70, 1468.
(50) Zhao, J.; Miao, H.; Duan, L.; Kang, Q.; He, L. The mass transfer process and the growth rate of NaCl crystal growth by evaporation based on temporal phase evaluation. Opt. Lasers Eng. 2012, 50, 540 – 546, Computational Optical Measurement.
(51) Banerjee, S.; Hashemi, M.; Lv, Z.; Maity, S.; Rochet, J. C.; Lyubchenko, Y. L. A novel pathway for amyloids self-assembly in aggregates at nanomolar concentration mediated by the interaction with surfaces. Sci. Rep. 2017, 7, 1–11.
(52) Pan, Y.; Banerjee, S.; Zagorski, K.; Shlyakhtenko, L. S.; Kolomeisky, A. B.; Lyubchenko, Y. L. Molecular model for the surface-catalyzed protein self-assembly. J. Phys. Chem. B 2020, 124, 366–372.
(53) Nakajima, K.; Ogi, H.; Adachi, K.; Noi, K.; Hirao, M.; Yagi, H.; Goto, Y. Nucleus factory on cavitation bubble for amyloid β fibril. Sci. Rep. 2016, 6, 1–10.
(54) Nakajima, K.; Nishioka, D.; Hirao, M.; So, M.; Goto, Y.; Ogi, H. Drastic acceleration of fibrillation of insulin by transient cavitation bubble. Ultrason. Sonochem. 2017, 36, 206–211.
(55) Nakajima, K.; So, M.; Takahashi, K.; Tagawa, Y. I.; Hirao, M.; Goto, Y.; Ogi, H. Optimized ultrasonic irradiation finds out ultrastable Aβ1−40 oligomers. J. Phys. Chem. B 2017, 121, 2603–2613.
(56) Zhang, Y.; Keller, D.; Rossell, M. D.; Erni, R. Formation of Au nanoparticles in liquid cell transmission electron microscopy: From a systematic study to engineered nanostructures. Chem. Mater. 2017, 29, 10518–10525.
(57) Schneider, N. M.; Norton, M. M.; Mendel, B. J.; Grogan, J. M.; Ross, F. M.; Bau, H. H. Electron–water interactions and implications for liquid cell electron microscopy. J. Phys. Chem. C 2014, 118, 22373–22382.
(58) Mirsaidov, U. M.; Zheng, H.; Bhattacharya, D.; Casana, Y.; Matsudaira, P. Direct observation of stick-slip movements of water nanodroplets induced by an electron beam. Proc. Natl. Acad. Sci. USA 2012, 109, 7187–7190.
(59) Grogan, J. M.; Schneider, N. M.; Ross, F. M.; Bau, H. H. Bubble and pattern formation in liquid induced by an electron beam. Nano Let. 2014, 14, 359–364.
論文の公開元へ
